Why the study?
Identifying cardiac tumors and establishing their differential diagnosis and optimal management remains challenging for cardiologists, while timely therapy can improve the poor prognosis of malignant cases.
Echocardiography, combined with clinical evaluation, is a crucial first step in the differential diagnosis and management of benign and malignant cardiac tumors.
Answers are grounded in this paper and cite their sources.
Supports echocardiography with clinical evaluation as first-line for cardiac tumors; leaves open need for prospective validation of multimodal algorithms.
Cardiac tumors may be primary (either benign or malignant) or secondary (malignant) and are first detected by echocardiography in most cases. The cardiologist often challenges their identification, the differential diagnosis and the best therapeutic approach. Malignant tumors have usually a poor prognosis, which may be significantly improved by appropriate and timely therapies. The echocardiographic aspects of benign and malignant cardiac tumors described in this article, along with a clinical evaluation may orient the differential diagnosis and aid in choosing the further steps useful to define the nature of the mass.
No takes yet. Share an insight, caveat, or question.
Pino et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: